Dissociation of GLP-1 and insulin association with food processing in the brain: GLP-1 sensitivity despite insulin resistance in obese humans

Molecular Metabolism

Volumn 4, Issue 12, 2015, Pages 971-976

  Heni, Martin ^a,b   Kullmann, Stephanie ^a,b   Gallwitz, Baptist ^a   Häring, Hans Ulrich ^a,b   Preissl, Hubert ^a,b   Fritsche, Andreas ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

Author keywords

Brain; Brain insulin resistance; FMRI; Glucagon like peptide 1; Incretin; Orbitofrontal cortex

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN;

ADULT; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLUCOSE BLOOD LEVEL; HORMONAL REGULATION; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE SENSITIVITY; HUMAN; HUNGER; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEAN BODY WEIGHT; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; ORBITAL CORTEX; PRIORITY JOURNAL;

EID: 84951127187     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2015.09.007     Document Type: Article

References (36)

1. Gallwitz B. Anorexigenic effects of GLP-1 and its analogues. Handbook of Experimental Pharmacology 2012, (209):185-207. 10.1007/978-3-642-24716-3_8.
2. Campbell J.E., Drucker D.J. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metabolism 2013, 17(6):819-837. 10.1016/j.cmet.2013.04.008.
3. Gallwitz B. Extra-pancreatic effects of incretin-based therapies. Endocrine 2014, 47(2):360-371. 10.1007/s12020-014-0223-0.
4. Vilsbøll T., Christensen M., Junker A.E., Knop F.K., Gluud L.L. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials. BMJ (Clinical Research Ed.) 2012, 344:d7771.
5. van Bloemendaal L., Kulve Ten J.S., la Fleur S.E., Ijzerman R.G., Diamant M. Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS. The Journal of Endocrinology 2014, 221(1):T1-T16. 10.1530/JOE-13-0414.
6. Flint A., Raben A., Astrup A., Holst J.J. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. The Journal of Clinical Investigation 1998, 101(3):515-520. 10.1172/JCI990.
7. Berthoud H.-R., Morrison C. The brain, appetite, and obesity. Annual Review of Psychology 2008, 59:55-92. 10.1146/annurev.psych.59.103006.093551.
8. Krieger J.-P., Langhans W., Lee S.J. Vagal mediation of GLP-1's effects on food intake and glycemia. Physiology & Behavior 2015, 10.1016/j.physbeh.2015.06.001.
9. Ueno H., Mizuta M., Shiiya T., Tsuchimochi W., Noma K., Nakashima N., et al. Exploratory trial of intranasal administration of glucagon-like peptide-1 in Japanese patients with type 2 diabetes. Diabetes Care 2014, 10.2337/dc13-0690.
10. van Bloemendaal L., IJzerman R.G., Kulve Ten J.S., Barkhof F., Konrad R.J., Drent M.L., et al. GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans. Diabetes 2014, 10.2337/db14-0849.
11. Heni M., Kullmann S., Ketterer C., Guthoff M., Bayer M., Staiger H., et al. Differential effect of glucose ingestion on the neural processing of food stimuli in lean and overweight adults. Human Brain Mapping 2014, 35(3):918-928. 10.1002/hbm.22223.
12. Meier J.J., Nauck M.A., Kranz D., Holst J.J., Deacon C.F., Gaeckler D., et al. Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects. Diabetes 2004, 53(3):654-662.
13. Bak M.J., Wewer Albrechtsen N.J., Pedersen J., Knop F.K., Vilsbøll T., Jørgensen N.B., et al. Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): implications for GLP-1 measurements in clinical studies. Diabetes, Obesity & Metabolism 2014, 16(11):1155-1164. 10.1111/dom.12352.
14. Kullmann S., Frank S., Heni M., Ketterer C., Veit R., Häring H.-U., et al. Intranasal insulin modulates intrinsic reward and prefrontal circuitry of the human brain in lean women. Neuroendocrinology 2012, 10.1159/000341406.
15. Kullmann S., Heni M., Veit R., Scheffler K., Machann J., Häring H.-U., et al. Selective insulin resistance in homeostatic and cognitive control brain areas in overweight and obese adults. Diabetes Care 2015, 10.2337/dc14-2319.
16. Heni M., Kullmann S., Ketterer C., Guthoff M., Linder K., Wagner R., et al. Nasal insulin changes peripheral insulin sensitivity simultaneously with altered activity in homeostatic and reward-related human brain regions. Diabetologia 2012, 55(6):1773-1782. 10.1007/s00125-012-2528-y.
17. Kullmann S., Heni M., Fritsche A., Preissl H. Insulin action in the human brain: evidence from neuroimaging studies. Journal of Neuroendocrinology 2015, 10.1111/jne.12254.
18. Ketterer C., Tschritter O., Preissl H., Heni M., Häring H.-U., Fritsche A. Insulin sensitivity of the human brain. Diabetes Research and Clinical Practice 2011, 93(Suppl. 1):S47-S51. 10.1016/S0168-8227(11)70013-4.
19. Myers M.G., Cowley M.A., Münzberg H. Mechanisms of leptin action and leptin resistance. Annual Review of Physiology 2008, 70:537-556. 10.1146/annurev.physiol.70.113006.100707.
20. Kringelbach M.L., O'Doherty J., Rolls E.T., Andrews C. Activation of the human orbitofrontal cortex to a liquid food stimulus is correlated with its subjective pleasantness. Cerebral Cortex (New York, N.Y.: 1991) 2003, 13(10):1064-1071.
21. Tataranni P.A., Gautier J.F., Chen K., Uecker A., Bandy D., Salbe A.D., et al. Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography. Proceedings of the National Academy of Sciences of the United States of America 1999, 96(8):4569-4574.
22. Kringelbach M.L. The human orbitofrontal cortex: linking reward to hedonic experience. Nature Reviews. Neuroscience 2005, 6(9):691-702. 10.1038/nrn1747.
23. Gottfried J.A., O'Doherty J., Dolan R.J. Encoding predictive reward value in human amygdala and orbitofrontal cortex. Science (New York, N.Y.) 2003, 301(5636):1104-1107. 10.1126/science.1087919.
24. Siep N., Roefs A., Roebroeck A., Havermans R., Bonte M.L., Jansen A. Hunger is the best spice: an fMRI study of the effects of attention, hunger and calorie content on food reward processing in the amygdala and orbitofrontal cortex. Behavioural Brain Research 2009, 198(1):149-158. 10.1016/j.bbr.2008.10.035.
25. Frank S., Laharnar N., Kullmann S., Veit R., Canova C., Hegner Y.L., et al. Processing of food pictures: influence of hunger, gender and calorie content. Brain Research 2010, 1350:159-166. 10.1016/j.brainres.2010.04.030.
26. Porubská K., Veit R., Preissl H., Fritsche A., Birbaumer N. Subjective feeling of appetite modulates brain activity: an fMRI study. NeuroImage 2006, 32(3):1273-1280. 10.1016/j.neuroimage.2006.04.216.
27. Su A.I., Wiltshire T., Batalov S., Lapp H., Ching K.A., Block D., et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(16):6062-6067. 10.1073/pnas.0400782101.
28. Wu C., Orozco C., Boyer J., Leglise M., Goodale J., Batalov S., et al. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biology 2009, 10(11):R130. 10.1186/gb-2009-10-11-r130.
29. De Silva A., Salem V., Long C.J., Makwana A., Newbould R.D., Rabiner E.A., et al. The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans. Cell Metabolism 2011, 14(5):700-706. 10.1016/j.cmet.2011.09.010.
30. van Bloemendaal L., Veltman D.J., Kulve Ten J.S., Groot P.F.C., Ruhé H.G., Barkhof F., et al. Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humans. Diabetes, Obesity & Metabolism 2015, 10.1111/dom.12506.
31. Daniele G., Iozzo P., Molina-Carrion M., Lancaster J., Ciociaro D., Cersosimo E., et al. Exenatide regulates cerebral glucose metabolism in brain areas associated with glucose homeostasis and reward system. Diabetes 2015, 10.2337/db14-1718.
32. Cabou C., Vachoux C., Campistron G., Drucker D.J., Burcelin R. Brain GLP-1 signaling regulates femoral artery blood flow and insulin sensitivity through hypothalamic PKC-δ. Diabetes 2011, 60(9):2245-2256. 10.2337/db11-0464.
33. Cabou C., Campistron G., Marsollier N., Leloup C., Cruciani-Guglielmacci C., Pénicaud L., et al. Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity. Diabetes 2008, 57(10):2577-2587. 10.2337/db08-0121.
34. Pannacciulli N., Le D.S.N.T., Salbe A.D., Chen K., Reiman E.M., Tataranni P.A., et al. Postprandial glucagon-like peptide-1 (GLP-1) response is positively associated with changes in neuronal activity of brain areas implicated in satiety and food intake regulation in humans. NeuroImage 2007, 35(2):511-517. 10.1016/j.neuroimage.2006.12.035.
35. Schlögl H., Kabisch S., Horstmann A., Lohmann G., Müller K., Lepsien J., et al. Exenatide-induced reduction in energy intake is associated with increase in hypothalamic connectivity. Diabetes Care 2013, 36(7):1933-1940. 10.2337/dc12-1925.
36. Batterham R.L., ffytche D.H., Rosenthal J.M., Zelaya F.O., Barker G.J., Withers D.J., et al. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 2007, 450(7166):106-109. 10.1038/nature06212.